TwinBeech Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
TwinBeech Capital's TXG Position: Q3 2026 in Review
TwinBeech Capital opened a new position in 10x Genomics (TXG) in Q3 2026: 27,700 shares worth $2.5M. The stake represents 0.58% of the portfolio and ranks #50 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in TXG as recently as Q3 2025.
TwinBeech Capital first reported a position in TXG in Q1 2020 and has held it in 10 quarters since. The position peaked at $6.84M in Q1 2022. 491 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- TwinBeech Capital held 27,700 shares of 10x Genomics worth $2.5M as of Q3 2026.
- 10x Genomics was a new TwinBeech Capital position in Q3 2026.
- 10x Genomics made up 0.58% of TwinBeech Capital's portfolio in Q3 2026, its #50 holding.
- TwinBeech Capital first reported a position in 10x Genomics in Q1 2020 and has held it in 10 quarters since.
- TwinBeech Capital's 10x Genomics position peaked at $6.84M in Q1 2022.
- 491 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.